STOCK TITAN

SRX GLOBAL INC Financials

SRXH
FY2025 annual
Revenue $6.5M -81.3% YoY
Net Income Not reported for FY2025
EPS (Diluted) -$2.13 -2030.0% YoY
Free Cash Flow Not reported for FY2025
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE September

SRX GLOBAL INC (SRXH) reported $6.5M in revenue for fiscal year 2025, down 81.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SRXH FY2025

Overhead-heavy operations overwhelmed a shrinking sales base, leaving external financing to bridge cash needs in FY2025.

FY2024's near-breakeven net loss masked a business that still burned $4.4M of operating cash; FY2025 then exposed the same mismatch when revenue fell to $6.5M and overhead stayed far above gross profit. The balance-sheet reset removed long-term debt, but financing inflows of $12.2M still had to offset operating cash flow of -$8.1M, so the company was not being funded by its own sales.

The current ratio of 2.3x looks comfortable, but cash was only $1.3M at FY2025 end, so short-term flexibility depends more on turning receivables and inventory into cash than on a cash reserve on hand.

Margin improvement without scale appeared in FY2024, when gross margin reached 37.1% even as sales fell, which points more to cost mix or lower product costs than to fixed-cost absorption. That benefit reversed to 23.4% in FY2025, showing how little cushion the model has when volume weakens.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 8 / 100
Financial Health Score 8/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of SRX GLOBAL INC's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
10
Dilution
4
R&D Intensity
0

Not available for SRX GLOBAL INC, and counted as zero in the overall score.

Revenue Progress
3
Burn Trend
0

Not available for SRX GLOBAL INC, and counted as zero in the overall score.

Balance Sheet
32
Altman Z-Score Distress
-4.92

SRX GLOBAL INC scores -4.92, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($25.9M) relative to total liabilities ($8.0M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
2/6

SRX GLOBAL INC passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). No profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Interest Coverage At Risk
N/A

SRX GLOBAL INC reported an operating loss of $11.4M against $628K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$6.5M
YoY-81.3%
5Y CAGR-31.3%

SRX GLOBAL INC generated $6.5M in revenue in fiscal year 2025. This represents a decrease of 81.3% from the prior year.

EBITDA
-$11.4M
YoY-94.9%

SRX GLOBAL INC's EBITDA was -$11.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 94.9% from the prior year.

EPS (Diluted)
-$2.13
YoY-2030.0%

SRX GLOBAL INC earned -$2.13 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 2030.0% from the prior year.

Net Income

Not reported for fiscal year 2025.

Cash & Balance Sheet

Cash & Debt
$1.3M
YoY-57.3%
5Y CAGR-19.7%

SRX GLOBAL INC held $1.3M in cash against $0 in long-term debt as of fiscal year 2025, with $3.5M of liabilities due within a year.

Shares Outstanding
25M
YoY+1258.1%

SRX GLOBAL INC had 25M shares outstanding in fiscal year 2025. This represents an increase of 1258.1% from the prior year.

Free Cash Flow

Not reported for fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
23.4%
YoY-13.8pp
5Y CAGR-14.5pp

SRX GLOBAL INC's gross margin was 23.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 13.8 percentage points from the prior year.

Operating Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not reported for fiscal year 2025.

Return on Equity

Not reported for fiscal year 2025.

Capital Allocation

Share Buybacks
$137K
YoY-33.5%

SRX GLOBAL INC spent $137K on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 33.5% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

Capital Expenditures

Not reported for fiscal year 2025.

SRXH Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SRXH annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
RevenueN/A$6.5M-81.3%$35.0M-9.4%$38.6M-29.4%$54.7M+18.8%$46.0M+8.0%$42.6M+173.4%$15.6MN/A$2K+3512.5%$48$0$0$0$0$0
Cost of RevenueN/A$5.0M-77.2%$22.0M-17.9%$26.8M-32.0%$39.4M+28.6%$30.6M+15.7%$26.5M+172.6%$9.7MN/A$334+6580.0%$5$0N/AN/AN/AN/A
Gross ProfitN/A$1.5M-88.3%$13.0M+10.1%$11.8M-22.7%$15.3M-0.7%$15.4M-4.6%$16.1M+174.8%$5.9MN/A$1K+3155.8%$43$0N/AN/AN/AN/A
R&D ExpensesN/AN/A$100K0.0%$100K-80.0%$500K0.0%$500K+400.0%$100KN/AN/AN/AN/AN/AN/AN/AN/AN/A
SG&A ExpensesN/A$12.9M-31.8%$19.0M-22.5%$24.4M-31.0%$35.4M+24.3%$28.5M-17.3%$34.5M+74.3%$19.8MN/AN/AN/A$7K-3.6%$7K+23.2%$6K+181.8%$2K-83.4%$13K
Operating IncomeN/A-$11.4M-91.2%-$6.0M+71.8%-$21.2M+45.4%-$38.8M-124.5%-$17.3M+36.8%-$27.3M+24.8%-$36.3MN/AN/AN/AN/AN/A-$22K-67.1%-$13K+66.3%-$39K
Interest ExpenseN/A$628K+34.5%$467K-65.5%$1.4M+145.6%$551K+117.1%-$3.2M-135.0%$9.2M+1214.3%$700K+31.4%$533KN/AN/AN/AN/AN/A$3K+66.6%$2K
Income TaxN/AN/A$9K+350.0%$2K+111.1%-$18K-148.6%$37K$0$0$0$0$0$0$0$0$0$0
Net IncomeN/AN/A-$168K+99.3%-$22.8M+42.1%-$39.3M-1260.8%$3.4M+105.7%-$59.3M+67.8%-$184.5MN/AN/AN/AN/AN/AN/A-$16K+61.1%-$41K
EPS (Diluted)-$2.13-2030.0%-$0.10-$32.29+45.2%-$58.93$0.14-$7.26N/AN/A-$0.02-100.0%-$0.01$0.00$0.00-$1.56-$0.26-$0.68

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

SRXH Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SRXH annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$8.4M-46.8%$15.8M-5.6%$16.7M-56.7%$38.7M-48.2%$74.7M+45.7%$51.3M-4.3%$53.5M+25504.1%$209K+1180.8%$16K-1.9%$17K+659.8%$2K-50.0%$4K-48.9%$9K-33.0%$13K-24.7%$17K
Current Assets$8.1M-45.8%$15.0M-7.6%$16.2M-41.0%$27.5M-37.3%$43.9M+150.1%$17.6M-0.1%$17.6M+8307.9%$209K+1180.8%$16K-1.9%$17K$0$0$0-100.0%$38+2.7%$37
Cash & Equivalents$1.3M-57.3%$3.1M-31.2%$4.5M+40.4%$3.2M-85.4%$21.7M+453.5%$3.9M+66.3%$2.4M+1082.4%$200K+13747.0%$1K-85.9%$10K$0$0$0-100.0%$38+2.7%$37
Inventory$2.1M-46.3%$3.9M-41.5%$6.6M-35.5%$10.3M+95.6%$5.2M+7.7%$4.9M-26.0%$6.6M+69885.1%$9K-36.8%$15K+132.6%$6K$0N/AN/AN/AN/A
Accounts Receivable$3.9M-26.5%$5.4M+23.4%$4.4M-35.4%$6.7M-0.7%$6.8M+46.7%$4.6M-20.5%$5.8MN/A$0-100.0%$45$0N/AN/AN/AN/A
GoodwillN/A$405KN/A$0-100.0%$18.6M0.0%$18.6M0.0%$18.6MN/AN/AN/AN/AN/AN/AN/AN/A
Total Liabilities$8.0M-89.9%$79.5M+477.6%$13.8M-19.8%$17.1M+2.2%$16.8M-78.8%$79.4M+58.6%$50.0M+712.0%$6.2M+413.8%$1.2M+102.9%$591K-75.4%$2.4M+6334.1%$37K-58.1%$89K+30.2%$69K+20.6%$57K
Current Liabilities$3.5M-50.4%$7.1M-47.8%$13.7M+145.4%$5.6M-24.0%$7.3M-86.5%$54.6M+65.3%$33.0M+1055.4%$2.9M+138.4%$1.2M+102.9%$591K+887.2%$60K+60.1%$37K-58.1%$89K+30.2%$69K+20.6%$57K
Long-Term Debt$0-100.0%$2.4M-47.8%$4.6M-59.6%$11.4M+21.6%$9.4M-61.7%$24.6M+50.2%$16.4M$0$0N/AN/AN/AN/AN/AN/A
Total Equity$407K+100.6%-$63.7M-2260.6%$2.9M-86.3%$21.5M-62.8%$57.9M+305.9%-$28.1M-297.4%-$7.1M-18.8%-$6.0M-403.3%-$1.2M-106.0%-$574K+76.1%-$2.4M-7180.9%-$33K+59.1%-$81K-44.6%-$56K-39.8%-$40K
Retained Earnings-$22.9M+92.9%-$321.5M-0.1%-$321.3M-7.6%-$298.6M-15.2%-$259.3M+0.5%-$260.6M-29.5%-$201.3M-3421.7%$6.1M+294.9%-$3.1M-127.7%-$1.4M-216.4%-$431K-13.0%-$382KN/A-$236KN/A

SRXH Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SRXH annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash FlowN/A-$8.1M-86.9%-$4.4M-4591.8%$97K+100.5%-$20.6M-73.3%-$11.9M-58.0%-$7.5M+64.2%-$21.0MN/A-$40KN/AN/AN/A-$17K+3.1%-$18K+3.5%-$18K
Capital ExpendituresN/AN/A$41K+127.8%$18K-90.9%$198K-43.9%$353K+133.8%$151K+37.3%$110K+254.8%$31K$0N/A$0N/AN/AN/AN/A
Free Cash FlowN/AN/A-$4.4M-5667.1%$79K+100.4%-$20.8M-69.9%-$12.2M-59.5%-$7.7M+63.7%-$21.1MN/A-$40KN/AN/AN/AN/AN/AN/A
Investing Cash FlowN/A$5.9M+362.2%-$2.3M-12411.1%-$18K+90.9%-$198K+43.9%-$353K-133.8%-$151K+99.3%-$20.2M-65083.9%-$31K$0N/A$0$0$0$0$0
Financing Cash Flow$82.6M$12.2M+133.2%$5.2M+202.4%-$5.1M-497.6%$1.3M-96.6%$37.2M+307.9%$9.1M-77.1%$39.8MN/A$31KN/AN/AN/A$17K-3.3%$18K-3.4%$18K
Share BuybacksN/A$137K-33.5%$206KN/A$0-100.0%$1.6M$0N/A$0$0N/AN/AN/AN/AN/AN/A

Not reported in any period shown, so not listed: Dividends Paid.

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

SRXH Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

SRXH annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross Margin23.4%-13.8pp37.1%+6.6pp30.6%+2.7pp27.9%-5.5pp33.4%-4.4pp37.8%+0.2pp37.6%N/A80.7%-8.8pp89.6%N/AN/AN/AN/AN/A
Operating Margin-174.6%-17.1%+37.8pp-54.9%+16.1pp-71.0%-33.4pp-37.6%+26.6pp-64.1%-233.2%N/AN/AN/AN/AN/AN/AN/AN/A
Net MarginN/A-0.5%+58.5pp-59.0%+12.9pp-71.9%-79.3pp7.4%-139.3%-1184.2%N/AN/AN/AN/AN/AN/AN/AN/A
Return on EquityN/AN/A-772.6%-590.0pp-182.6%-188.5pp5.9%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Return on AssetsN/A-1.1%+135.0pp-136.1%-34.4pp-101.6%-106.2pp4.5%+120.3pp-115.8%+228.8pp-344.6%N/AN/AN/AN/AN/AN/A-124.3%+116.1pp-240.4%
Current Ratio2.29+0.2x2.10+0.9x1.19-3.7x4.93-1.0x5.98+5.7x0.32-0.2x0.53+0.5x0.07+0.1x0.010.0x0.030.0x0.000.0x0.000.0x0.000.0x0.000.0x0.00
Debt-to-Equity0.00N/A1.57+1.0x0.53+0.4x0.16N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
FCF MarginN/A-12.6%-12.8pp0.2%+38.2pp-38.0%-11.4pp-26.5%-8.6pp-18.0%-135.3%N/A-2292.7%N/AN/AN/AN/AN/AN/A

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Frequently Asked Questions

What is SRX GLOBAL INC's annual revenue?

SRX GLOBAL INC (SRXH) reported $6.5M in total revenue for fiscal year 2025. This represents a -81.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is SRX GLOBAL INC's revenue growing?

SRX GLOBAL INC (SRXH) revenue declined by 81.3% year-over-year, from $35.0M to $6.5M in fiscal year 2025.

What is SRX GLOBAL INC's earnings per share (EPS)?

SRX GLOBAL INC (SRXH) reported diluted earnings per share of -$2.13 for fiscal year 2025. This represents a -2030.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

SRX GLOBAL INC (SRXH) had EBITDA of -$11.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, SRX GLOBAL INC (SRXH) had $1.3M in cash and equivalents against $0 in long-term debt.

SRX GLOBAL INC (SRXH) had a gross margin of 23.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

SRX GLOBAL INC (SRXH) recorded an outflow of $8.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

SRX GLOBAL INC (SRXH) had $8.4M in total assets as of fiscal year 2025, including both current and long-term assets.

Yes, SRX GLOBAL INC (SRXH) spent $137K on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

SRX GLOBAL INC (SRXH) had 25M shares outstanding as of fiscal year 2025.

SRX GLOBAL INC (SRXH) had a current ratio of 2.29 as of fiscal year 2025, which is generally considered healthy.

SRX GLOBAL INC (SRXH) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Based on fiscal year 2025 data, SRX GLOBAL INC (SRXH) had $1.3M in cash against an annual operating cash burn of $8.1M. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

SRX GLOBAL INC (SRXH) has an Altman Z-Score of -4.92, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

SRX GLOBAL INC (SRXH) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

SRX GLOBAL INC (SRXH) reported an operating loss of $11.4M against $628K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

SRX GLOBAL INC (SRXH) scores 8 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top